SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 17th, 2017 • Vermillion, Inc. • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledFebruary 17th, 2017 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”) dated February 13, 2017, is entered into by and among (i) Vermillion, Inc., a Delaware corporation (the “Company”), and (ii) each investor listed on Schedule I (each, an “Investor” and, collectively, the “Investors”).